James Healy SEC insider filings

Historical public-company ownership and transaction filings, with links to the original SEC records.

What the SEC filings show

James Healy is named as a reporting owner in 4 source-backed SEC filings in this collection, associated with 3 public-company issuers. The most recent included filing was submitted Oct 30, 2026.

Filings may report stock transactions or holdings at a particular time. They do not establish the person's current share balance, portfolio value, total net worth, or whether a transaction was an open-market purchase or sale.

Source filings
4
Issuers represented
3
Filings with transactions
4
Filings with holdings
0

Recent SEC source documents

A selection of the latest 3 relevant source filings. Counts describe reported rows in the filing, not verified trades, economic proceeds, or personal profits. Older filings and amendments may contain different information.

FiledIssuerReported relationshipRowsOriginal SEC filing
Oct 30, 2026Rapport Therapeutics, Inc.Director4 transaction / 0 holdingForm 4 · 0001104659-26-120789
May 27, 2015Coherus BioSciences, Inc.Director6 transaction / 0 holdingForm 4/A · 0001209191-15-047125
May 8, 2015HYPERION THERAPEUTICS INCDirector, 10% owner10 transaction / 0 holdingForm 4 · 0001209191-15-040840

How to interpret this evidence

SEC Forms 3, 4 and 5 disclose certain ownership and transaction observations. Reporting dates, beneficial ownership, derivative instruments, indirect positions and amendments can affect interpretation. Figures here are counts of filing records, not independent valuations. Exact total net worth is not publicly known from this filing record.

Browse this reporting owner's SEC filing history

Explore people and ownership research